T13603 |
CDDO-3P-Im
|
1883650-95-0
|
97.13%
|
|
CDDO-3P-Im is an orally active inhibitor of necroptosis with chemopreventive effects. CDDO-3P-Im can be used in studies about ischemia/reperfusion.
|
T37558 |
Necrostatin-5
|
337349-54-9
|
98.03%
|
|
Necrostatin-5 (Nec-5) is a selective inhibitor of RIP1 kinase and a cell necrosis inhibitor that prevents the death of Fadd-deficient Jurkat cells treated with T...
|
T64349 |
Necroptosis-IN-3
|
547698-18-0
|
98.33%
|
|
Necroptosis-IN-3 (Cyclohexanecarboxamide, N-(2-thienylmethyl)-) (Compound 69) is a Necroptosis inhibitor that inhibits TNF-α induced necroptosis. Necroptosis-IN-...
|
T80286 |
TP4 (Nile tilapia piscidin)
|
1429184-62-2
|
98%
|
|
TP4 (Nile tilapia piscidin) is an orally active piscidin-like antimicrobial peptide that exhibits inhibition of various gram-positive and negative bacterial stra...
|
T79731 |
MLKL-IN-6
|
|
98%
|
|
MLKL-IN-6 (compound P28) is a mixed lineage kinase inhibitor that specifically targets the Mixed Lineage Kinase domain-like (MLKL) protein. It effectively preven...
|
T79707 |
Cholicamideβ
|
|
98%
|
|
Cholicamideβ (compound 6), a self-assembling small molecule cancer vaccine adjuvant, forms low cytotoxicity virus-like particles and upon binding to peptide anti...
|
T79605 |
RIP1 kinase inhibitor 8
|
2226735-54-0
|
98%
|
|
RIP1 Kinase Inhibitor 8 (Compound 77), a potent and highly selective dihydropyrazole (DHP) RIP1 kinase inhibitor, exhibits an IC50 of 20 nM and effectively preve...
|
T79347 |
Anticancer agent 146
|
|
98%
|
|
Anticancer Agent 146 (Compound 1.19) acts as a necroptosis inducer and demonstrates anti-tumor efficacy in the MDA-MB-231 mouse xenograft model [1].
|